Construction and in vivo evaluation of a mammary gland-specific expression vector for human lysozyme

被引:3
作者
Li, Guocai [1 ,2 ,3 ]
Shi, Weiqing [4 ]
Chen, Gang [2 ]
Chen, Hongju [1 ,3 ]
Jiao, Hongmei [1 ,3 ]
Yan, Hua [1 ,3 ]
Ji, Mingchun [1 ,3 ]
Sun, Huaichang [2 ]
机构
[1] Yangzhou Univ, Sch Med, Dept Pathogeniol & Immunol, Yangzhou 225001, Jiangsu, Peoples R China
[2] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Jiangsu Key Lab Zoonosis, Yangzhou 225009, Peoples R China
[3] Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Peoples R China
[4] Jiangsu Prov Ctr Dis Control & Prevent, Dept Pathol, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Human lysozyme; Mammary gland-specific expression vector; Transgenic mouse; HIGH-LEVEL EXPRESSION; ACTIVE HUMAN ALPHA-1-ANTITRYPSIN; TRANSGENIC ANIMAL BIOREACTORS; RECOMBINANT HUMAN LYSOZYME; BETA-LACTOGLOBULIN GENE; SACCHAROMYCES-CEREVISIAE; ECTOPIC EXPRESSION; HUMAN LACTOFERRIN; GROWTH-HORMONE; FUSION GENES;
D O I
10.1016/j.plasmid.2014.09.004
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A mammary gland-specific expression vector p205C3 was constructed with the 5'- and 3'-flanking regions of beta-lactoglobulin gene and the first intron of beta-casein gene of Chinese dairy goat as regulatory sequences. Human lysozyme (hLYZ) cDNA from mammary gland was cloned into p2050 and the recombinant vector was used to generate transgenic mice by microinjection. Based on the lysoplate assay, four female offspring of one male founder were detected expressing recombinant hLYZ in their milk at the levels of 5-200 mg/l, and the expressed protein had the same molecular weight as that of normal hLYZ. Besides mammary glands, ectopic expressions were also found in the spleens and the small intestines of the transgenic mice. Among the offspring, the female transgenic mice maintained and expressed the transgene stably with a highest expression level of 750 mg/l. Therefore, p2050 could be used to develop animal mammary gland bioreactors expressing hLYZ. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 51 条
[1]   HIGH-LEVEL EXPRESSION OF BIOLOGICALLY-ACTIVE HUMAN ALPHA-1-ANTITRYPSIN IN THE MILK OF TRANSGENIC MICE [J].
ARCHIBALD, AL ;
MCCLENAGHAN, M ;
HORNSEY, V ;
SIMONS, JP ;
CLARK, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5178-5182
[2]   Milk composition studies in transgenic goats expressing recombinant human butyrylcholinesterase in the mammary gland [J].
Baldassarre, Hernan ;
Hockley, Duncan K. ;
Olaniyan, Benjamen ;
Brochu, Eric ;
Zhao, Xin ;
Mustafa, Arif ;
Bordignon, Vilceu .
TRANSGENIC RESEARCH, 2008, 17 (05) :863-872
[3]   ECTOPIC EXPRESSION OF BETA-LACTOGLOBULIN HUMAN SERUM-ALBUMIN FUSION GENES IN TRANSGENIC MICE - HORMONAL-REGULATION AND IN-SITU LOCALIZATION [J].
BARASH, I ;
FAERMAN, A ;
RATOVITSKY, T ;
PUZIS, R ;
NATHAN, M ;
HURWITZ, DR ;
SHANI, M .
TRANSGENIC RESEARCH, 1994, 3 (03) :141-151
[4]   THE ISOLATION AND CHARACTERIZATION OF LYSOZYME FROM HUMAN-FETAL MEMBRANES - A COMPARISON WITH THE ENZYME FROM OTHER SOURCES [J].
BARLING, PM ;
JOHN, MJ ;
WALSH, JR ;
NIALL, HD .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1985, 81 (02) :509-513
[5]   CLONING OF HUMAN LYSOZYME GENE AND EXPRESSION IN THE YEAST SACCHAROMYCES-CEREVISIAE [J].
CASTANON, MJ ;
SPEVAK, W ;
ADOLF, GR ;
CHLEBOWICZSLEDZIEWSKA, E ;
SLEDZIEWSKI, A .
GENE, 1988, 66 (02) :223-234
[6]   TRANSGENIC ANIMALS AS BIOREACTORS FOR PHARMACOLOGICAL PRODUCTS [J].
COSTA, P ;
SASSANO, M ;
RIGHI, M ;
RICCIARDICASTAGNOLI, P .
PHARMACOLOGICAL RESEARCH, 1990, 22 (02) :75-78
[7]  
Damert Annette, 2003, Methods Mol Med, V89, P513
[8]   Transgenic rabbits as therapeutic protein bioreactors and human disease models [J].
Fan, JL ;
Watanabe, T .
PHARMACOLOGY & THERAPEUTICS, 2003, 99 (03) :261-282
[9]   COMPLETE SEQUENCE OF THE CAPRINE BETA-LACTOGLOBULIN GENE [J].
FOLCH, JM ;
COLL, A ;
SANCHEZ, A .
JOURNAL OF DAIRY SCIENCE, 1994, 77 (12) :3493-3497
[10]  
Fujiwara Y, 1999, MOL REPROD DEV, V52, P414, DOI 10.1002/(SICI)1098-2795(199904)52:4<414::AID-MRD10>3.0.CO